These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 36518456)

  • 1. A survey on the incidence of common musculoskeletal side effects among the patients taking long-term anti-ulcerant therapies in Bangladesh.
    Mitra S; Hussain MS; Rahman R; Salam MA; Mazumder T; Farzana S
    Toxicol Rep; 2022; 9():1796-1805. PubMed ID: 36518456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zollinger-Ellison syndrome. Clinical presentation in 261 patients.
    Roy PK; Venzon DJ; Shojamanesh H; Abou-Saif A; Peghini P; Doppman JL; Gibril F; Jensen RT
    Medicine (Baltimore); 2000 Nov; 79(6):379-411. PubMed ID: 11144036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger-Ellison Syndrome.
    Lee L; Ramos-Alvarez I; Ito T; Jensen RT
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31623145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
    Freedberg DE; Kim LS; Yang YX
    Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
    ;
    Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitor-induced gut dysbiosis and immunomodulation: current knowledge and potential restoration by probiotics.
    Kiecka A; Szczepanik M
    Pharmacol Rep; 2023 Aug; 75(4):791-804. PubMed ID: 37142877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Proton Pump Inhibitors in the Management of Upper Gastrointestinal Disorders.
    Ali Khan M; Howden CW
    Gastroenterol Hepatol (N Y); 2018 Mar; 14(3):169-175. PubMed ID: 29928161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review of the Novel Application and Potential Adverse Effects of Proton Pump Inhibitors.
    Yu LY; Sun LN; Zhang XH; Li YQ; Yu L; Yuan ZQ; Meng L; Zhang HW; Wang YQ
    Adv Ther; 2017 May; 34(5):1070-1086. PubMed ID: 28429247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing proton pump inhibitors with histamin-2 receptor blockers regarding the risk of osteoporotic fractures: a nested case-control study of more than 350,000 Korean patients with GERD and peptic ulcer disease.
    Park JH; Lee J; Yu SY; Jung JH; Han K; Kim DH; Rhee J
    BMC Geriatr; 2020 Oct; 20(1):407. PubMed ID: 33059626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Association Between Prolonged Proton Pump Inhibitors Use and Bone Mineral Density.
    Fattahi MR; Niknam R; Shams M; Anushiravani A; Taghavi SA; Omrani GR; Mahmoudi L
    Risk Manag Healthc Policy; 2019; 12():349-355. PubMed ID: 31853206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of short-and long-term medical treatment of gastroesophageal reflux disease (GERD).
    Pohle T; Domschke W
    Langenbecks Arch Surg; 2000 Aug; 385(5):317-23. PubMed ID: 11026702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitors for preventing non-steroidal anti-inflammatory drug induced gastrointestinal toxicity: a systematic review.
    Yang M; He M; Zhao M; Zou B; Liu J; Luo LM; Li QL; He JH; Lei PG
    Curr Med Res Opin; 2017 Jun; 33(6):973-980. PubMed ID: 28076696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD
    Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term use of proton pump inhibitors adversely affects minerals and vitamin metabolism, bone turnover, bone mass, and bone strength.
    Hussain MS; Mazumder T
    J Basic Clin Physiol Pharmacol; 2022 Sep; 33(5):567-579. PubMed ID: 34687598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal.
    Savarino V; Dulbecco P; de Bortoli N; Ottonello A; Savarino E
    Eur J Intern Med; 2017 Jan; 37():19-24. PubMed ID: 27784575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Use of Proton-Pump Inhibitors: Unravelling the Safety Puzzle.
    Bhatnagar MS; Choudhari S; Pawar D; Sharma A
    Cureus; 2024 Jan; 16(1):e52773. PubMed ID: 38389608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders.
    Richardson P; Hawkey CJ; Stack WA
    Drugs; 1998 Sep; 56(3):307-35. PubMed ID: 9777309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical use of proton pump inhibitors in gastrointestinal diseases].
    Rew JS
    Korean J Gastroenterol; 2006 Mar; 47(3):181-90. PubMed ID: 16554671
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.